SMSbiotech, Inc
Founded 2015
About SMSbiotech, Inc
SMSbiotech is pioneering a revolutionary cell therapy that offers a potential cure for COPD and other debilitating diseases. Our breakthrough technology harnesses the power of Small Mobile Stem (SMS) cells, which we discovered and named, to regenerate damaged lung tissue. Imagine restoring healthy lung function in just 10 days. Our animal studies have demonstrated this remarkable potential. What sets us apart is our off-the-shelf, non-invasive treatment: healthy human adult blood-derived SMS cells delivered directly to the lungs via a simple nebulizer. With 16 patents filed and 6 granted, we are currently advancing our first-in-human phase 1 safety trial, bringing hope to patients worldwide.
Company Facts
- Founded: 2015
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Website: smsbiotech.com
- Phone: 760-290-3406
Social Profiles
Canonical: https://fsome.com/organization/smsbiotech-inc-8376318 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.